Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A E Till

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Biopharmaceutics & Drug Disposition|January 1, 1982
Evidence for route dependent biotransformation of cyclobenzaprine hydrochlorideA E Till, M L Constanzer, J Demetriades, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1974
Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothinC S Goodwin, E B Raftery, A D Goldberg, et al.
European Journal of Clinical Pharmacology|December 19, 1975
Serum concentrations of ampicillin and probenecid and ampicillin excretion after repeated oral administration of a pivampicillin-probenecid salt (MK-356)H G Kampffmeyer, I Hartmann, H Metz, et al.
Journal of Pharmaceutical Sciences|November 1, 1984
Influence of food on the bioavailability of enalaprilB N Swanson, P H Vlasses, R K Ferguson, et al.
British Journal of Clinical Pharmacology|April 1, 1987
The pharmacokinetics of enalapril in hospitalized patients with congestive heart failureK Dickstein, A E Till, T Aarsland, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1993
Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and humanR A Halpin, E H Ulm, A E Till, et al.
Biopharmaceutics & Drug Disposition|July 1, 1984
Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteersA E Till, H J Gomez, M Hichens, et al.
Cardiology|January 1, 1990
Lovastatin versus bezafibrate: efficacy, tolerability, and effect on urinary mevalonateF U Beil, A Schrameyer-Wernecke, U Beisiegel, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521): disposition in manE H Ulm, M Hichens, H J Gomez, et al.
Kidney International. Supplement|May 1, 1987
Disposition of enalapril and enalaprilat in renal insufficiencyR J Fruncillo, M L Rocci, P H Vlasses, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Biopharmaceutics & Drug Disposition|January 1, 1982
Evidence for route dependent biotransformation of cyclobenzaprine hydrochlorideA E Till, M L Constanzer, J Demetriades, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1974
Effects of rate of infusion and probenecid on serum levels, renal excretion, and tolerance of intravenous doses of cefoxitin in humans: comparison with cephalothinC S Goodwin, E B Raftery, A D Goldberg, et al.
European Journal of Clinical Pharmacology|December 19, 1975
Serum concentrations of ampicillin and probenecid and ampicillin excretion after repeated oral administration of a pivampicillin-probenecid salt (MK-356)H G Kampffmeyer, I Hartmann, H Metz, et al.
Journal of Pharmaceutical Sciences|November 1, 1984
Influence of food on the bioavailability of enalaprilB N Swanson, P H Vlasses, R K Ferguson, et al.
British Journal of Clinical Pharmacology|April 1, 1987
The pharmacokinetics of enalapril in hospitalized patients with congestive heart failureK Dickstein, A E Till, T Aarsland, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1993
Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and humanR A Halpin, E H Ulm, A E Till, et al.
Biopharmaceutics & Drug Disposition|July 1, 1984
Pharmacokinetics of repeated single oral doses of enalapril maleate (MK-421) in normal volunteersA E Till, H J Gomez, M Hichens, et al.
Cardiology|January 1, 1990
Lovastatin versus bezafibrate: efficacy, tolerability, and effect on urinary mevalonateF U Beil, A Schrameyer-Wernecke, U Beisiegel, et al.
British Journal of Clinical Pharmacology|September 1, 1982
Enalapril maleate and a lysine analogue (MK-521): disposition in manE H Ulm, M Hichens, H J Gomez, et al.
Kidney International. Supplement|May 1, 1987
Disposition of enalapril and enalaprilat in renal insufficiencyR J Fruncillo, M L Rocci, P H Vlasses, et al.
Pageof 2